SELARL DE PHARMACIENS D'OFFICINE MILIANI-B : revenue, balance sheet and financial ratios

SELARL DE PHARMACIENS D'OFFICINE MILIANI-B is a French company founded 10 years ago, specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé. Based in BERRE-L'ETANG (13130), this company of category PME shows in 2017 a revenue of 1.6 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-09

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - SELARL DE PHARMACIENS D'OFFICINE MILIANI-B (SIREN 813538154)
Indicator 2017 2016
Revenue 1 582 160 € 1 826 273 €
Net income 40 720 € 15 243 €
EBITDA 103 185 € 82 066 €
Net margin 2.6% 0.8%

Revenue and income statement

In 2017, SELARL DE PHARMACIENS D'OFFICINE MILIANI-B achieves revenue of 1.6 M€. Significant drop of -13% vs 2016. After deducting consumption (1.1 M€), gross margin stands at 483 k€, i.e. a rate of 31%. This ratio measures the ability to generate value from commercial activity. EBITDA (= Gross margin - Personnel expenses - Taxes) reaches 103 k€, representing 6.5% of revenue. Positive scissor effect: EBITDA margin improves by +2.0 pts, sign of improved operational efficiency. The operating margin remains fragile, requiring cost vigilance. Ultimately, net income (= EBIT +/- financial result +/- exceptional - corporate tax) amounts to 41 k€, i.e. 2.6% of revenue. This profit can be retained or distributed to shareholders.

Revenue (2017) ?
Revenue
Definition
Total amount of sales of goods and services made by the company.
Formula
Sales of goods + Sold production

1 582 160 €

Gross margin (2017) ?
Gross margin
Definition
Difference between revenue and cost of goods sold.
Formula
Revenue - Cost of goods consumed

483 198 €

EBITDA (2017) ?
Gross Operating Surplus (EBITDA)
Definition
Resources generated by current operations, before depreciation and financial expenses.
Formula
Value added - Personnel expenses - Taxes
Interpretation
Positive = profitable activity

103 185 €

EBIT (2017) ?
EBIT (Operating Income)
Definition
Operating income, including depreciation and provisions.
Formula
EBITDA - Depreciation and provisions + Reversals

61 856 €

Net income (2017) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

40 720 €

EBITDA margin (2017) ?
EBITDA margin
Definition
Measures the company's operating profitability.
Formula
(EBE / CA) x 100
Interpretation
> 10% : Good profitability
5-10% : Average
< 5% : Low

6.5%

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 937%. Critical situation: debt significantly exceeds equity, severely limiting borrowing capacity and exposing the company to default risk. Financial autonomy (= Equity / Total assets x 100) reaches 8%. Low autonomy: the company heavily depends on external financing (banks, suppliers). Debt repayment capacity (= Financial debt / Cash flow) indicates it would take 12.5 years of cash flow to repay all financial debt. Beyond 7 years, banks generally consider credit risk as high. Cash flow represents 5.7% of revenue. Cash flow measures resources generated by operations, available for investment and debt repayment. Satisfactory level allowing partial financing of growth.

Debt ratio (2017) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

936.834%

Financial autonomy (2017) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

8.093%

Cash flow / Revenue (2017) ?
Cash flow / Revenue
Definition
Self-financing capacity relative to revenue.
Formula
(CAF / CA) x 100
Interpretation
The higher the ratio, the more cash the company generates

5.712%

Repayment capacity (2017) ?
Repayment capacity
Definition
Number of years needed to repay debts with cash flow.
Formula
Financial debt / Cash flow
Interpretation
< 3 years : Excellent
3-5 years : Fair
> 5 years : Warning

12.539

Asset age ratio (2017) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

71.5%

Solvency indicators evolution
SELARL DE PHARMACIENS D'OFFICINE MILIANI-B

Sector positioning

Debt ratio
936.83 2017
2016
2017
Q1: 44.02
Med: 127.97
Q3: 288.72
Watch

In 2017, the debt ratio of SELARL DE PHARMACIENS D'O... (936.83) ranks in the top 25% of the sector. This ratio measures the weight of debt relative to equity. A high ratio may indicate excessive dependence on external financing.

Financial autonomy
8.09% 2017
2016
2017
Q1: 20.08%
Med: 35.55%
Q3: 55.69%
Watch

In 2017, the financial autonomy of SELARL DE PHARMACIENS D'O... (8.1%) ranks in the bottom 25% of the sector. This ratio represents the share of equity in total financing. Low autonomy may limit investment capacity and increase vulnerability.

Repayment capacity
12.54 years 2017
2016
2017
Q1: 2.26 years
Med: 5.88 years
Q3: 10.41 years
Average

In 2017, the repayment capacity of SELARL DE PHARMACIENS D'O... (12.54) ranks above the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A reduction effort could improve financial strength.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 90.39. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months. The interest coverage ratio (= EBIT / Interest expenses) is 20.9x. Operating income very largely covers interest expenses: high safety margin.

Liquidity ratio (2017) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

90.39

Interest coverage (2017) ?
Interest coverage
Definition
Ability to cover interest charges with operating income.
Formula
EBIT / Interest expenses
Interpretation
> 3 : Comfortable
1.5-3 : Acceptable
< 1.5 : Risk

20.861

Liquidity indicators evolution
SELARL DE PHARMACIENS D'OFFICINE MILIANI-B

Sector positioning

Liquidity ratio
90.39 2017
2016
2017
Q1: 115.53
Med: 157.05
Q3: 219.24
Watch

In 2017, the liquidity ratio of SELARL DE PHARMACIENS D'O... (90.39) ranks in the bottom 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio below 1 may signal potential cash flow tensions.

Interest coverage
20.86x 2017
2016
2017
Q1: 2.81x
Med: 8.18x
Q3: 15.34x
Excellent

In 2017, the interest coverage of SELARL DE PHARMACIENS D'O... (20.9x) ranks in the top 25% of the sector. This ratio indicates how many times operating income covers interest expenses. High coverage means financial charges weigh little on profitability.

Working capital requirement (WCR) and payment terms

Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 6 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 46 days. Excellent situation: suppliers finance 40 days of the operating cycle (retail model). Inventory turnover is 24 days (= Average inventory / Cost of goods x 360). Fast turnover, sign of good inventory management. Overall, WCR represents 19 days of revenue, i.e. 84 k€ to permanently finance.

Operating WCR (2017) ?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released
Positive = financing needed

83 981 €

Customer credit (2017) ?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good
45-60j : Average
> 60j : Long

6 j

Supplier credit (2017) ?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow

46 j

Inventory turnover (2017) ?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover

24 j

WCR in days of revenue (2017) ?
WCR in days of revenue
Definition
Expresses working capital requirement in days of revenue.
Formula
(Operating WCR / Revenue) x 360
Interpretation
The fewer days, the better the working capital management

19 j

WCR and payment terms evolution
SELARL DE PHARMACIENS D'OFFICINE MILIANI-B

Positioning of SELARL DE PHARMACIENS D'OFFICINE MILIANI-B in its sector

Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé

Valuation estimate

Based on 82 transactions of similar company sales in 2017, the value of SELARL DE PHARMACIENS D'OFFICINE MILIANI-B is estimated at 829 605 € (range 709 308€ - 1 077 813€). With an EBITDA of 103 185€, the sector multiple of 7.5x is applied. The price/revenue ratio is 0.74x (in line with sector norms). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Medium reliability: estimate to be confirmed with in-depth analysis.

Estimated enterprise value 2017
82 tx
709k€ 829k€ 1077k€
829 605 € Range: 709 308€ - 1 077 813€
NAF 5 année 2017

Valuation detail by method

Ajustez les pondérations selon votre analyse

EBITDA Multiple 50%
103 185 € × 7.5x
Estimation 770 090 €
650 537€ - 1 115 272€
Revenue Multiple 30%
1 582 160 € × 0.74x
Estimation 1 173 703 €
1 056 937€ - 1 305 955€
Net Income Multiple 20%
40 720 € × 11.4x
Estimation 462 249 €
334 796€ - 641 954€

Valuation evolution

How is this estimate calculated?

This estimate is based on the analysis of 82 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)

Compare SELARL DE PHARMACIENS D'OFFICINE MILIANI-B with other companies in the same sector:

Voir toutes les statistiques du secteur Commerce de détail de produits pharmaceutiques en magasin spécialisé

Frequently asked questions about SELARL DE PHARMACIENS D'OFFICINE MILIANI-B

What is the revenue of SELARL DE PHARMACIENS D'OFFICINE MILIANI-B ?

The revenue of SELARL DE PHARMACIENS D'OFFICINE MILIANI-B in 2017 is 1.6 M€.

Is SELARL DE PHARMACIENS D'OFFICINE MILIANI-B profitable?

Yes, SELARL DE PHARMACIENS D'OFFICINE MILIANI-B generated a net profit of 41 k€ in 2017.

Where is the headquarters of SELARL DE PHARMACIENS D'OFFICINE MILIANI-B ?

The headquarters of SELARL DE PHARMACIENS D'OFFICINE MILIANI-B is located in BERRE-L'ETANG (13130), in the department Bouches-du-Rhone.

Where to find the tax return of SELARL DE PHARMACIENS D'OFFICINE MILIANI-B ?

The tax return of SELARL DE PHARMACIENS D'OFFICINE MILIANI-B is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does SELARL DE PHARMACIENS D'OFFICINE MILIANI-B operate?

SELARL DE PHARMACIENS D'OFFICINE MILIANI-B operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.